skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: Título de revista: Haematologica eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy
The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy
Material Type:
Artículo 		Añadir a Mi Portal

The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy

Pavlasova, Gabriela ; Mraz, Marek

Haematologica (Roma), 2020-06, Vol.105 (6), p.1494-1506 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
2
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
Material Type:
Artículo 		Añadir a Mi Portal

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Lucchini, Elisa ; Zaja, Francesco ; Bussel, James

Haematologica (Roma), 2019-06, Vol.104 (6), p.1124-1135 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
3
International recommendations on the diagnosis and treatment of acquired hemophilia A
International recommendations on the diagnosis and treatment of acquired hemophilia A
Material Type:
Artículo 		Añadir a Mi Portal

International recommendations on the diagnosis and treatment of acquired hemophilia A

Tiede, Andreas ; Collins, Peter ; Knoebl, Paul ; Teitel, Jerome ; Kessler, Craig ; Shima, Midori ; Di Minno, Giovanni ; d'Oiron, Roseline ; Salaj, Peter ; Jiménez-Yuste, Victor ; Huth-Kühne, Angela ; Giangrande, Paul

Haematologica (Roma), 2020-07, Vol.105 (7), p.1791-1801 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
4
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Material Type:
Artículo 		Añadir a Mi Portal

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

Kastritis, Efstathios ; Kyrtsonis, Marie-Christine ; Morel, Pierre ; Gavriatopoulou, Maria ; Hatjiharissi, Evdoxia ; Symeonidis, Argirios S ; Vassou, Amalia ; Repousis, Panagiotis ; Delimpasi, Sossana ; Sioni, Anastasia ; Michalis, Evrydiki ; Michael, Michail ; Vervessou, Elina ; Voulgarelis, Michael ; Tsatalas, Costantinos ; Terpos, Evangelos ; Dimopoulos, Meletios A

Haematologica (Roma), 2015-11, Vol.100 (11), p.e446-e449 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
5
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Material Type:
Artículo 		Añadir a Mi Portal

Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab

Bacova, Barbora ; Kohutova, Zuzana ; Zubata, Ivana ; Gaherova, Lubica ; Kucera, Petr ; Heizer, Tomas ; Mikesova, Marcela ; Karel, Tomas ; Novak, Jan

Clinical and experimental medicine, 2023-06, Vol.23 (2), p.371-379 [Revista revisada por pares]

Cham: Springer International Publishing

Texto completo disponible

Citas Citado por
6
Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial
Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

Xiong, Wenjie ; Lyu, Rui ; Yu, Ying ; Wang, Tingyu ; Yan, Yuting ; Wang, Yi ; Liu, Wei ; An, Gang ; Deng, Shuhui ; Xu, Yan ; Sui, Weiwei ; Huang, Wenyang ; Zou, Dehui ; Wang, Jianxiang ; Qiu, Lugui ; Yi, Shuhua

Haematologica (Roma), 2024-05, Vol.109 (5), p.1614-1618 [Revista revisada por pares]

Italy: Fondazione Ferrata Storti

Texto completo disponible

Citas Citado por
7
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
Material Type:
Artículo 		Añadir a Mi Portal

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study

Bolen, Christopher R ; Klanova, Magdalena ; Trneny, Marek ; Sehn, Laurie H ; He, Jie ; Tong, Jing ; Paulson, Joseph N ; Kim, Eugene ; Vitolo, Umberto ; Di Rocco, Alice ; Fingerle-Rowson, Günter ; Nielsen, Tina ; Lenz, Georg ; Oestergaard, Mikkel Z

Haematologica (Roma), 2020-09, Vol.105 (9), p.2298-2307 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
8
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
Material Type:
Artículo 		Añadir a Mi Portal

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study

Rezazadeh, Alexandra ; Szabo, Aniko ; Khurana, Arushi ; Inwards, David J ; Lunning, Matthew A ; Bartlett, Nancy L ; Caimi, Paolo F ; Rodgers, Thomas D ; Barr, Paul M ; Chowdhury, Sayan Mullick ; Epperla, Narendranath ; Mendries, Hiruni ; Hill, Brian T ; Oh, Timothy S ; Karmali, Reem ; Chang, Julie E ; Goyal, Gaurav ; Parsons, Benjamin M ; Isaac, Krista M ; Portell, Craig A ; Monahan, Kathleen ; Siker, Malika ; King, David M ; Fenske, Timothy S

Haematologica (Roma), 2024-05, Vol.109 (5), p.1439-1444 [Revista revisada por pares]

Italy: Fondazione Ferrata Storti

Texto completo disponible

Citas Citado por
9
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
Material Type:
Artículo 		Añadir a Mi Portal

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

Gressin, Rémy ; Daguindau, Nicolas ; Tempescul, Adrian ; Moreau, Anne ; Carras, Sylvain ; Tchernonog, Emmanuelle ; Schmitt, Anna ; Houot, Roch ; Dartigeas, Caroline ; Pignon, Jean Michel ; Corm, Selim ; Banos, Anne ; Mounier, Christiane ; Dupuis, Jehan ; Macro, Margaret ; Fleury, Joel ; Jardin, Fabrice ; Sarkozy, Clementine ; Damaj, Ghandi ; Feugier, Pierre ; Fornecker, Luc Matthieu ; Chabrot, Cecile ; Dorvaux, Veronique ; Bouadallah, Krimo ; Amorin, Sandy ; Garidi, Reda ; Voillat, Laurent ; Joly, Bertrand ; Celigny, Philippe Solal ; Morineau, Nadine ; Moles, Marie Pierre ; Zerazhi, Hacene ; Fontan, Jean ; Arkam, Yazid ; Alexis, Magda ; Delwail, Vincent ; Vilque, Jean Pierre ; Ysebaert, Loic ; Le Gouill, Steven ; Callanan, Mary B

Haematologica (Roma), 2019-01, Vol.104 (1), p.138-146 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
10
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Material Type:
Artículo 		Añadir a Mi Portal

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Sacchi, Stefano ; Marcheselli, Raffaella ; Bari, Alessia ; Buda, Gabriele ; Molinari, Anna Lia ; Baldini, Luca ; Vallisa, Daniele ; Cesaretti, Marina ; Musto, Pellegrino ; Ronconi, Sonia ; Specchia, Giorgina ; Silvestris, Franco ; Guardigni, Luciano ; Ferrari, Angela ; Chiapella, Annalisa ; Carella, Angelo Michele ; Santoro, Armando ; Di Raimondo, Francesco ; Marcheselli, Luigi ; Pozzi, Samantha

Haematologica (Roma), 2016-05, Vol.101 (5), p.e196-e199 [Revista revisada por pares]

Italy: Ferrata Storti Foundation

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Recursos en línea (246)
  2. Revistas arbitradas (246)

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de2003  (21)
  2. 2003Hasta2007  (76)
  3. 2008Hasta2012  (46)
  4. 2013Hasta2018  (55)
  5. Después de 2018  (51)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora